Breaking News

Watson Marlow Acquires Asepco

Expands sterile bioprocessing portfolio

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Watson-Marlow Fluid Technology Group has acquired Asepco through its parent company Spirax-Sarco Engineering, for £7.0 million. Asepco, based in CA, specializes in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.   Asepco expands Watson-Marlow’s fluid path product portfolio and global presence in the biotechnology and pharmaceutical industries. Asepco uses patented technology to improve sterility levels within the biotechnology producti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters